95G-21461-55351
3 vaccinations
8 coded responses
24 check-ins
8 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 334 / FL
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Pfizer-BioNTech
- 2021-04-09
-
2021-04-10
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Tenderness an injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Tenderness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-13
- 2021-04-14
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-07-09
Survey response — 3 months, dose 1MedDRA: Arthralgia, Neuralgia, Office visit — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Experienced right side face trigeminal neurological symptoms ( pain in right eye, right ear, and face) Also, severe joint pains in left hip, and right hand · Healthcare visit (other): Saw a retinal specialist, and my primary care mdMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-14
- 2021-10-08
-
2021-12-18
Dose 3 — Pfizer-BioNTech
- 2021-12-18
-
2021-12-19
Survey response — days 1–6 daily, dose 3MedDRA: Malaise, Syncope — Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Malaise, syncopeMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-12-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-12-24
- 2021-12-25
-
2022-01-01
Survey response — day 14, dose 3MedDRA: Chills, Headache, Night sweats, Oropharyngeal pain, Pain, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sore throat, chills, runny nose, night sweats, body aches, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-01-08
Survey response — day 21, dose 3MedDRA: Ageusia, Anosmia, Cough, Night sweats, Oropharyngeal pain, Pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sore throat, cough, body aches, night sweats, loss of taste and smellMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Survey response — day 28, dose 3MedDRA: Cough, Night sweats, Oropharyngeal pain, Pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cough, sore throat, achey , night sweats, runny nose, and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-01-22
- 2022-01-29
- 2022-03-19
-
2022-06-20
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Positive for CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-06-20
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-06-21
- 2022-06-21
-
2022-06-21
Call successfulParticipant prefers to complete VAERS report online
-
2022-06-21
Call successfulParticipant prefers to complete VAERS report online
- 2022-12-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | No |
| 3 | 2021-12-18 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Tenderness an injection site
Systemic reaction (other): Tenderness at injection site
Release 9 — 3 months, dose 1
Symptoms: Experienced right side face trigeminal neurological symptoms ( pain in right eye, right ear, and face) Also, severe joint pains in left hip, and right hand
Healthcare visit (other): Saw a retinal specialist, and my primary care md
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Malaise, syncope
Release 10 — day 14, dose 3
Symptoms: Sore throat, chills, runny nose, night sweats, body aches, headache
Release 10 — day 21, dose 3
Symptoms: Sore throat, cough, body aches, night sweats, loss of taste and smell
Release 10 — day 28, dose 3
Symptoms: Cough, sore throat, achey , night sweats, runny nose, and congestion
Release 12 — 6 months, dose 3
Symptoms: Positive for Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Neuralgia | ✓ | ✓ | ✓ |
| SD | Night sweats | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Malaise | · | · | ✓ |
| SRO | Syncope | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release